Home › Kanker (alle vormen) › New Mexico › Albuquerque
Kanker (alle vormen) klinische studies in Albuquerque, NM
14 studies voor Kanker (alle vormen) zoeken deelnemers op locaties in en rond Albuquerque (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
RekruterenFase 3
- University of New Mexico Cancer Center, Albuquerque
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RekruterenFase 2
- Lovelace Medical Center - Saint Joseph Square, Albuquerque
- Presbyterian Kaseman Hospital, Albuquerque
- The University of New Mexico Comprehensive Cancer Center, Albuquerque
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
RekruterenFase 2
- University of New Mexico, School of Medicine, Albuquerque
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
RekruterenFase 1/2
- Research Site, Albuquerque
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
RekruterenFase 3
- University of New Mexico Comprehensive Cancer Center, Albuquerque
Project: Every Child for Younger Patients With Cancer
RekruterenObservatieonderzoek
- Presbyterian Hospital, Albuquerque
- University of New Mexico Cancer Center, Albuquerque
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
RekruterenFase 3
- University of New Mexico Cancer Center, Albuquerque
Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological Cancers
RekruterenFase 2
- 292, Albuquerque
Molecular Genetics Studies of Cancer Patients and Their Relatives
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- Lovelace Medical Center-Downtown, Albuquerque
- New Mexico Oncology Hematology Consultants, Albuquerque
- Presbyterian Kaseman Hospital, Albuquerque
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
Rekruteren
- University of New Mexico Comprehensive Cancer Center, Albuquerque
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, Albuquerque
A Prospective Registry to Enable Collection of Standardized Routine Care Oncology Patient Data
RekruterenObservatieonderzoekGezonde vrijwilligers welkom
- New Mexico Oncology Hematology Consultants, Albuquerque
Total Cancer Care Protocol: A Lifetime Partnership With Patients Who Have or May be at Risk of Having Cancer
RekruterenObservatieonderzoek
- University of New Mexico Comprehensive Cancer Center, Albuquerque
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Rekruteren
- Lovelace Medical Centre-Saint Joseph Square, Albuquerque
- Lovelace Women's Hospital, Albuquerque
Kanker (alle vormen) studies in andere steden
- Houston, TX121 studies
- New York City, NY109 studies
- Boston, MA85 studies
- Los Angeles, CA74 studies
- Nashville, TN65 studies
- Philadelphia, PA59 studies
- Washington, DC58 studies
- Durham, NC58 studies
- Chicago, IL51 studies
- Atlanta, GA49 studies
- Seattle, WA49 studies
- Arlington, VA48 studies
Andere studies in Albuquerque
- Niet-kleincellige longkanker18 studies
- Borstkanker17 studies
- Eierstokkanker15 studies
- Longkanker14 studies
- Metastatische kanker12 studies
- Endometriumkanker12 studies
- Type 2-diabetes11 studies
- Cardiovasculaire ziekte10 studies
- Melanoom9 studies
- Acute myeloïde leukemie9 studies
- Prostaatkanker9 studies
- Chronische nierziekte8 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.